BRICs Nations Growing Impact on the Global Health Sector

The most notable feature of the past five centuries of global economic history dating back from Colonial Age until the present accelerated globalization is the persistence of «North–South» division between the global rich and poor. This ground pattern has been falling apart over the last three decades with the rise of BRICs emerging economies (Brazil, Russia, India, China). The Chinese Belt and Road Initiative fosters further rapid growth and synergy among these large nations. This ambitious and historically unprecedented infrastructural project if successful can lead to a formation by 2049 of a huge common economic zone bringing opportunities for multilateral development to the BRICs. These profound changes have deep implications for the global health care sector. Previous research on health and pharmaceutical spending has clearly documented that low- and middle-income economies (LMICs), led by these emerging markets, have doubled their share in global health spending from roughly 20% up to approximately 40% in purchasing power parity terms. Alongside with these global developments, a decade ago, some of the leading Western academic centers, confirm new era of rising world’s geo-economic and geopolitical multipolarity. The world witnesses this process being accelerated today and seek deeper understanding how it will reflect on long term health and pharmaceutical expenditure trends, particularly in the leading BRICs emerging markets being a front runner of such evolution.

The authors declare absence of conflict of interests.

1. Allen R.C. 2005. A Reassessment of the Soviet Industrial Revolution. Comparative Economic Studies. 47 (2). P.315-332. DOI: 10.1057/palgrave.ces.8100101

2. Arsentiev E.V., Reshetnikov V.A. 2018. K biografii N.A. Semashko: deyatel'nost' pervogo narkoma zdravookhraneniya v 1920-1925 gg. [On the Biography of N. Semashko: the Activities of the First People’s Commissar of Health in 1920-1925]. Istoriya Meditsiny. 5(3). P.217-229. DOI: 10.17720/2409-5583.t5.4.2018.05e (in Russian)

3. Davydova T.V. 2015. Reformirovaniye sovetskogo zdravookhraneniya v poslevoyennyye gody: istoricheskiy analiz [Reform of Soviet Healthcare in the Postwar Years: a Historical Analysis]. Bulletin of the Tambov University. Series: Humanities. 8(148). P.164-170. (In Russian)

4. De Cordier B. 2016. Russia's International Aid Donorship: from Diplomatic Status Symbol to “Frontline Aid”? Global Affairs. 2(1). P.21-34.

5. Fatykhova V.M. 2019. Yevraziyskoye sotrudnichestvo v oblasti nauki i vysshego obrazovaniya: perspektivy neofunktsional'nogo «peretekaniya» [Eurasian Cooperation in the Field of Science and Higher Education: Perspectives of Unofficial “Flowing”]. MGIMO Review of International Relations, 2(65). P.159-175. DOI: 10.24833/2071-8160-2019-2-65-159-175 (In Russian)

6. Friedman Y. 2010. Location of Pharmaceutical Innovation: 2000-2009. Nature Review. Drug Discovey. 9(11). P.835-836. DOI: 10.1038/nrd3298

7. Gusterson H. 2017. From Brexit to Trump: Anthropology and the Rise of Nationalist Populism. American Ethnologist. 44(2). DOI: 10.1111/amet.12469

8. Ivins C. 2013. Inequality Matters: BRICS Inequalities Fact Sheet. Oxfam Policy and Practice: Climate Change and Resilience. 9(1). P.39-50.

9. Jakovljevic M., Fernandes P.O., Teixeira J.P., Rancic N., Timofeyev Y., Reshetnikov V. 2019. Underlying Differences in Health Spending within the World Health Organization Europe Region — Comparing EU15, EU post-2004, CIS, EU Candidate, and CARINFONET Countries. International Journal of Environmental Research and Public Health. 16(17). DOI: 10.3390/ijerph16173043

10. Jakovljevic M., Getzen T.E. 2016. Growth of Global Health Spending Share in Low and Middle Income Countries. Frontiers of Pharmacology. 7: 21. DOI: 10.3389/fphar.2016.00021

11. Jakovljevic M., Groot W., Souliotis K. 2016. Health Care Financing and Affordability in the Emerging Global Markets. Frontiers in Public Health. 4:2. DOI: 10.3389/fpubh.2016.00002

12. Jakovljevic M., Jakab M., Gerdtham U., McDaid D., Ogura S., Varavikova E., . Getzen T.E. 2019. Comparative Financing Analysis and Political Economy of Noncommunicable Diseases. Journal of Medical Economics. 22(8). P.722-727. DOI: 10.1080/13696998.2019.1600523

13. Jakovljević M., Jovanović M., Lazić Z., Jakovljević V., Đukić A., Velicković R., Antunović M. 2011. Current Efforts and Proposals to Reduce Healthcare Costs in Serbia. Serbian Journal of Experimental and Clinical Research. 12(4). P.161-163.

14. Jakovljevic M., Lazarevic M., Milovanovic O., Kanjevac T. 2016. The New and Old Europe: East-West Split in Pharmaceutical Spending. Frontiers in Pharmacology. 7:18. DOI: 10.3389/ fphar.2016.00018

15. Jakovljevic M., Timofeyev Y., Ekkert N.V., Fedorova J.V., Skvirskaya G., Bolevich S., Reshetnikov V.A. 2019. The Impact of Health Expenditures on Public Health in BRICS Nations. Journal of Sport and Health Science. 8(6): P.516-519.

16. Jakovljevic M.B. 2013. Resource Allocation Strategies in Southeastern European Health Policy. European Journal of Health Economics. 14. P.153-159. DOI: 10.1007/s10198-012-0439-y

17. Jakovljevic M.B. 2014. The Key Role of the Leading Emerging BRIC Markets in the Future of Global Health Care. Serbian Journal of Experimental and Clinical Research. 15(3). P.139-143. DOI: 10.2478/sjecr-2014-0018

18. Jakovljevic M.B. 2015. BRIC’s Growing Share of Global Health Spending and Their Diverging Pathways. Frontiers in Public Health. 3: 135. DOI: 10.3389/fpubh.2015.00135

19. Jakovljevic M.B., Milovanovic O. 2015. Growing Burden of Non-Communicable Diseases in the Emerging Health Markets: the Case of BRICS. Frontiers of Public Health. 3: 65. DOI: 10.3389/fpubh.2015.00065

20. Jakovljevic M.M. 2016. Comparison of Historical Medical Spending Patterns among the BRICS and G7. Journal of medical economics. 19(1). P.70-76. DOI: 10.3111/13696998.2015.1093493

21. Karavaeva E.I. 2004. Zakonodatel'stvo Rossiyskoy Federatsii o zdravookhranenii (istoriya, sovremennoye sostoyaniye, tendentsii razvitiya) [The Legislation of the Russian Federation on Health Care (History, Current Status, Development Trends)]. Siberian Law Journal. 2. P.24-28. (In Russian)

22. Kravets O., Sandikci O. 2014. Competently Ordinary: New Middle Class Consumers in the Emerging Markets. Journal of Marketing. 78(4). P.125-140. DOI: 10.1509/jm.12.0190

23. Kumar A., Juluru K., Thimmaraju P.K., Reddy J., Patil A. 2014. Pharmaceutical Market Access in Emerging Markets: Concepts, Components, and Future. Journal of Market Access & Health Policy. 2(1). 25302. DOI: 10.3402/jmahp.v2.25302

24. Loeppke R., Nicholson S., Taitel M., Sweeney M., Haufle V., Kessler R.C. 2008. The Impact of an Integrated Population Health Enhancement and Disease Management Program on Employee Health Risk, Health Conditions, and Productivity. Population Health Management. 11(6). P.287-296. DOI: 10.1089/pop.2008.0006

25. Marten R., McIntyre D., Travassos C., Shishkin S., Longde W., Reddy S., Vega J. 2014. An Assessment of Progress towards Universal Health Coverage in Brazil, Russia, India, China, and South Africa (BRICS). The Lancet. 384(9960). P.2164-2171. DOI: 10.1016/S0140- 6736(14)60075-1

26. Ogura S., Jakovljevic M. 2014. Health Financing Constrained by Population Aging-An Opportunity to Learn from Japanese Experience. Serbian Journal of Experimental and Clinical Research. 15(4). P.175-181. DOI: 10.2478/sjecr-2014-0022

27. Rancic N., Jakovljevic M.M. 2016. Long Term Health Spending alongside Population Aging in N-11 Emerging Nations. East Eur Bus Economic Journal. 2(1). P.2-26.

28. Reshetnikov V., Arsentyev E., Boljevic S., Timofeyev Y., Jakovljević M. 2019. Analysis of the Financing of Russian Health Care over the Past 100 Years. International Journal of Environmental Research and Public Health. 16(10). DOI: 10.3390/ijerph16101848

29. Roberts P.C. 2013.The Failure of Laissez Faire Capitalism and Economic Dissolution of the West: towards a New Economics for a Full World. Atwell Publishing. 190 p.

30. Rossabi M. (Ed.). 1983. China among Equals: the Middle Kingdom and Its Neighbors, 10th 14th centuries. University of California Press. 400 p.

31. Schoen C., Collins S.R., Kriss J.L., Doty M.M. 2008. How Many Are Underinsured? Trends Among US Adults, 2003 And 2007: Growing Numbers of Adults with Insurance Find that They Are not Adequately Protected from the Rising Cost of Health Care. Health Affairs. 27(4):w298- 309. DOI: 10.1377/hlthaff.27.4.w298

32. Shkolnikov A.Yu. 2019. Geostrategicheskiy vzglyad na budushcheye Rossii [Geostrategic View of the Future of Russia]. Svobodnaya Mysl’. 2. P. 5-34. (In Russian)

33. Tang M., Hussler C. 2011. Betting on Indigenous Innovation or Relying on FDI: The Chinese Strategy for Catching-up. Technology in Society. 33(1-2). P.23-35. DOI: 10.1016/j.techsoc.2011.03.001

34. Vogel E.F. 2011. Deng Xiaoping and the Transformation of China. Belknap Press of Harvard University Press. 928 p.

35. Wittfogel K.A. 1935. The Foundations and Stages of Chinese Economic History. Zeitschrift für Sozialforschung. 4(26). P.26-60.

36. Xie Y., Zhou X. 2014. Income Inequality in Today’s China. Proceedings of the National Academy of Sciences. 111(19). P.6928-6933. DOI: 10.1073/pnas.1403158111